UNLIMITED TURBO SHORT - ROCHE GS Share Price

Certificat

TVQABP

CH1237348631

Real-time Bid/Ask 09:00:29 05/07/2024 BST
4.79 CHF / 4.8 CHF -4.86% Intraday chart for UNLIMITED TURBO SHORT - ROCHE GS
Current month+13.26%
1 month-16.83%
Date Price Change
04/07/24 5.04 +6.11%
03/07/24 4.75 +5.56%
02/07/24 4.5 +2.74%
01/07/24 4.38 -1.57%
28/06/24 4.45 +2.30%

Delayed Quote Swiss Exchange

Last update July 04, 2024 at 04:20 pm

More quotes

Static data

Product typeKnock-Out ohne Stop Loss
Buy / SellPUT
Underlying ROCHE HOLDING AG
IssuerLogo Issuer BNP Paribas BNP Paribas
TVQABP
ISINCH1237348631
Date issued 08/02/2023
Strike 292.5 CHF
Maturity Unlimited
Parity 10 : 1
Emission price- CHF
Emission volume N/A
Settlement Barausgleich
Currency CHF

Technical Indicators

Highest since issue 8.24 CHF
Lowest since issue 2.11 CHF
Spread 0.01 CHF
Spread %0.21%

Company Profile

Roche Holding AG (Roche) is a research-based healthcare company. The Company's operating businesses are organized into two divisions: Pharmaceuticals and Diagnostics. The Pharmaceuticals Division consists of two business segments: Roche Pharmaceuticals and Chugai. The Diagnostics Division consists of four business areas: Diabetes Care, Molecular Diagnostics, Professional Diagnostics and Tissue Diagnostics. The Company develops medicines for various disease areas, including oncology, immunology, infectious diseases, ophthalmology and neuroscience. Its pharmaceutical products include Anaprox, Avastin, Bactrim, Bondronat, CellCept, Cotellic, Dilatrend, Dormicum, Invirase, Kadcyla, Kytril (Kevatril), Lariam, MabThera, Madopar, Neupogen, Pegasys, Perjeta, Pulmozyme, Rocaltrol, Rocephin and Roferon-A. The Company offers products for researchers, including cell analysis, gene expression, genome sequencing and nucleic acid purification.
Sector
-
More about the company

Ratings for Roche Holding AG

Trading Rating
Investor Rating
ESG Refinitiv
A+
More Ratings

Consensus: Roche Holding AG

Sell
Consensus
Buy
Mean consensus
HOLD
Number of Analysts
20
Last Close Price
243.4 CHF
Average target price
276.4 CHF
Spread / Average Target
+13.57%
Consensus
  1. Stock Market
  2. Certificates
  3. TVQABP Certificat